Goldman Sachs Group Inc Clear Point Neuro, Inc. Transaction History

Goldman Sachs Group Inc

  • $780 Billion
  • Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 105,107 shares of CLPT stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,107
Previous 286,792 63.35%
Holding current value
$1.63 Million
Previous $3.42 Million 33.12%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$10.0 - $21.79 $1.82 Million - $3.96 Million
-181,685 Reduced 63.35%
105,107 $2.29 Million
Q2 2025

Aug 14, 2025
BUY
$10.51 - $14.71 $303,959 - $425,427
28,921 Added 11.22%
286,792 $3.42 Million
Q1 2025

May 09, 2025
BUY
$11.89 - $18.8 $1.52 Million - $2.4 Million
127,823 Added 98.29%
257,871 $3.07 Million
Q4 2024

Feb 11, 2025
BUY
$10.74 - $16.68 $1.08 Million - $1.68 Million
100,898 Added 346.13%
130,048 $2 Million
Q3 2024

Nov 14, 2024
SELL
$5.3 - $13.18 $516,400 - $1.28 Million
-97,434 Reduced 76.97%
29,150 $326,000
Q2 2024

Aug 13, 2024
BUY
$5.25 - $6.73 $421,559 - $540,398
80,297 Added 173.48%
126,584 $682,000
Q1 2024

May 15, 2024
SELL
$6.03 - $7.86 $1,670 - $2,177
-277 Reduced 0.59%
46,287 $314,000
Q4 2023

Feb 13, 2024
SELL
$4.46 - $7.07 $3,202 - $5,076
-718 Reduced 1.52%
46,564 $316,000
Q3 2023

May 14, 2024
BUY
$5.01 - $7.09 $3,597 - $5,090
718 Added 1.54%
47,282 $236,000
Q3 2023

Nov 14, 2023
BUY
$5.01 - $7.09 $236,882 - $335,229
47,282 New
47,282 $236,000
Q1 2023

May 14, 2024
BUY
$7.33 - $10.63 $439,455 - $637,300
59,953 Added 139.8%
102,838 $867,000
Q1 2023

May 11, 2023
BUY
$7.33 - $10.63 $439,455 - $637,300
59,953 Added 139.8%
102,838 $867,000
Q4 2022

May 14, 2024
BUY
$7.7 - $11.21 $55,486 - $80,779
7,206 Added 20.2%
42,885 $363,000
Q4 2022

Feb 13, 2023
BUY
$7.7 - $11.21 $55,486 - $80,779
7,206 Added 20.2%
42,885 $363,000
Q3 2022

May 14, 2024
SELL
$9.82 - $16.49 $90,707 - $152,318
-9,237 Reduced 20.57%
35,679 $370,000
Q3 2022

Nov 10, 2022
SELL
$9.82 - $16.49 $90,707 - $152,318
-9,237 Reduced 20.57%
35,679 $369,000
Q2 2022

May 14, 2024
SELL
$7.09 - $13.65 $11,684 - $22,495
-1,648 Reduced 3.54%
44,916 $586,000
Q2 2022

Aug 15, 2022
SELL
$7.09 - $13.65 $76,231 - $146,764
-10,752 Reduced 19.31%
44,916 $586,000
Q1 2022

May 16, 2022
BUY
$7.8 - $11.6 $108,186 - $160,892
13,870 Added 33.18%
55,668 $580,000
Q4 2021

Feb 14, 2022
SELL
$11.08 - $18.86 $764,110 - $1.3 Million
-68,963 Reduced 62.26%
41,798 $469,000
Q3 2021

Nov 10, 2021
BUY
$16.58 - $22.25 $1.84 Million - $2.46 Million
110,761 New
110,761 $1.97 Million

Others Institutions Holding CLPT

# of Institutions
114
Shares Held
8.38M
Call Options Held
437K
Put Options Held
199K
View Full List

About ClearPoint Neuro, Inc.

CLPT Quotes by TradingView
  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $379M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email